{'52WeekChange': 0.24957263,
 'SandP52WeekChange': 0.0644362,
 'address1': '2400 District Avenue',
 'address2': 'Suite 310',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 8.4,
 'askSize': 800,
 'averageDailyVolume10Day': 64275,
 'averageVolume': 143273,
 'averageVolume10days': 64275,
 'beta': 0.477935,
 'beta3Year': None,
 'bid': 7.1,
 'bidSize': 800,
 'bookValue': 2.626,
 'category': None,
 'circulatingSupply': None,
 'city': 'Burlington',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 7.53,
 'dayLow': 7.2,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -3.011,
 'enterpriseToRevenue': None,
 'enterpriseValue': 99291296,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 7.548857,
 'fiftyTwoWeekHigh': 11.99,
 'fiftyTwoWeekLow': 4.01,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 7163719,
 'forwardEps': -1.9,
 'forwardPE': -3.8473685,
 'fromCurrency': None,
 'fullTimeEmployees': 15,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.109680004,
 'heldPercentInstitutions': 0.60118,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/scpharmaceuticals.com',
 'longBusinessSummary': 'scPharmaceuticals Inc., a pharmaceutical company, '
                        'engages in the development and commercialization of '
                        "various pharmaceutical products. The company's lead "
                        'product candidate is Furoscix that consists of '
                        'proprietary buffered formulation of furosemide, which '
                        'is delivered through the SmartDose drug delivery '
                        'system for treatment of congestion in decompensated '
                        'heart failure patients. Its product pipeline also '
                        'includes scCeftriaxone, an antibiotic to treat '
                        'infections caused by gram-positive and gram-negative '
                        'organisms; and scCarbapenem program, an antibiotic '
                        'for treating infections caused by gram-negative '
                        'organisms. The company has a development agreement '
                        'with West Pharmaceutical Services, Inc. to '
                        'incorporate SmartDose drug delivery system with '
                        'Furoscix. The company was founded in 2013 and is '
                        'headquartered in Burlington, Massachusetts.',
 'longName': 'scPharmaceuticals Inc.',
 'market': 'us_market',
 'marketCap': 195840752,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_247375245',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -31369000,
 'nextFiscalYearEnd': 1640908800,
 'open': 7.43,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '617-517-0730',
 'previousClose': 7.41,
 'priceHint': 2,
 'priceToBook': 2.7837014,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 7.53,
 'regularMarketDayLow': 7.2,
 'regularMarketOpen': 7.43,
 'regularMarketPreviousClose': 7.41,
 'regularMarketPrice': 7.43,
 'regularMarketVolume': 79239,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 26790800,
 'sharesPercentSharesOut': 0.0082,
 'sharesShort': 218854,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 32090,
 'shortName': 'scPharmaceuticals Inc.',
 'shortPercentOfFloat': 0.0153,
 'shortRatio': 1.11,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'SCPH',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.65,
 'twoHundredDayAverage': 8.004856,
 'volume': 79239,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.scpharmaceuticals.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '01803'}